AJG stock · REPL stock

AJG vs REPL · P/E 33, rev $11.55B vs $825.7M cap

Arthur J Gallagher & Co (AJG) versus Replimune Group Inc (REPL) — a side-by-side from cached financials, not a winner call.

Arthur J Gallagher & Co (AJG) is a insurance brokers company listed on US.

Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.

Latest reported AJG revenue for 2024-12-31 was $11.55B. Net income was $1.47B. Revenue was up 14.7% from 2023-12-31 to 2024-12-31. AJG currently screens at market cap $52.03B and trailing P/E 32.8.

REPL does not have a complete income-statement cache yet.

AJG currently screens at market cap $52.03B and trailing P/E 32.8. REPL currently screens at market cap $825.7M.

Not investment advice. Open the AJG and REPL stock pages for the full models.

Not investment advice.

Popular Stock Comparisons